认知矫正治疗联合行为减重与单纯行为减重治疗肥胖的比较:随机对照试验研究方案
本研究为双盲随机对照试验,计划纳入176名肥胖参与者,随机分为单纯行为减重组(8次个体行为减重会话加12次团体行为减重会话)或认知矫正治疗联合行为减重组(8次个体认知矫正治疗加12次团体行为减重会话)。主要结局为两组间体重下降百分比、执行功能、暴食的差异,以及执行功能变化是否预测体重和暴食变化。测量点包括基线、治疗后和1年随访。
要点
- 肥胖个体存在执行功能认知缺陷,高水平炎症可能参与其中。
- 研究比较认知矫正治疗联合行为减重与单纯行为减重,采用双盲设计和主动对照。
- 主要结局包括体重下降百分比、执行功能、暴食及执行功能变化对体重和暴食的预测。
核心结论
- 若认知矫正治疗联合行为减重在长期帮助减重方面比单纯行为减重更有效,应能显著改善治疗结局。
- 本研究扩展了近期试验,该试验显示认知矫正治疗改善了肥胖成人的执行功能和体重下降。
研究设计与样本
- 随机对照试验,计划纳入176名肥胖参与者,随机分配至单纯行为减重组或认知矫正治疗联合行为减重组。
- 单纯行为减重组接受8次个体行为减重会话加12次团体行为减重会话。
- 认知矫正治疗联合行为减重组接受8次个体认知矫正治疗加12次团体行为减重会话。
- 研究为双盲,参与者仅被告知比较两种减重治疗,研究助理进行结局评估时不知分组。
- 测量点包括基线、治疗后和1年随访,血液检测测量炎症标志物。
主要发现
- 主要结局为两组间体重下降百分比、执行功能、暴食的差异,以及执行功能变化是否预测体重和暴食变化。
- 次要结局包括炎症、生活质量、 grazing behaviour(放牧行为)的变化,以及这些变化是否预测执行功能和体重的变化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Current research indicates that obese individuals have cognitive deficits in executive function, leading to difficulties with planning, impulse control and decision-making. High levels of inflammation have been proposed to contribute to executive function deficits in individuals with obesity. METHODS/DESIGN: One hundred and seventy-six obese participants will be randomly assigned to one of two groups: (1) behavioural weight loss alone (BWL) group = 8 sessions of individual BWL sessions plus 12 group BWL sessions or (2) Cognitive Remediation Therapy for Obesity (CRT-O) plus BWL group (CRT-O + BWL) = 8 sessions of individual CRT-O plus 12 group BWL sessions. The study is double blind - participants will only be told that two weight-loss treatments are being compared and research assistants conducting outcome assessments will not know participants' group allocation. Blood tests will be conducted to measure inflammatory markers. Measurement points will be at baseline, post treatment and 1-year follow-up. The primary outcomes will be differences between treatment groups in percentage weight loss, executive function, binge eating and an examination of whether changes in executive function predict changes in weight and binge eating. Secondary outcome measures will examine changes on inflammation, quality of life, and grazing behaviour and whether these predict changes in executive function and weight. DISCUSSION: If CRT-O + BWL is more effective in assisting people to lose weight long term than BWL alone it should significantly improve treatment outcomes. This study expands upon our recent trial which showed that CRT-O enhanced executive function and weight loss in obese adults. The current study is strengthened by several factors: it is double-blind, it uses an active control, has a larger sample size, and measures inflammation to examine the mechanisms. TRIAL REGISTRATION: The RCT is registered with the Australian New Zealand Registry of Clinical Trial, trial identifier: ACTRN12616000658415 . Registered on 20 May 2016.
引用
- Smith E, Whittingham C. Cognitive remediation therapy plus behavioural weight loss compared to behavioural weight loss alone for obesity: study protocol for a randomised controlled trial. Trials. 2017. PMID: 28126015. doi:10.1186/s13063-017-1778-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。